ALMU director corrects Form 4; 33,800 shares sold at $16.18
Rhea-AI Filing Summary
Aeluma, Inc. (ALMU) director Mark N. Tompkins amended a prior Form 4 to correct the number of common shares sold and to disclose the weighted average sale price. The amendment shows a sale of 33,800 shares on 09/30/2025 at a weighted average price of $16.18, with the reporter retaining 2,857,033 shares after the transaction. The filing states the shares were sold in multiple transactions at prices ranging from $15.86 to $16.75 and that the amendment fixes a discrepancy in the original October 2 report.
The filing is a technical correction rather than a new transaction disclosure: the reporter affirms willingness to provide details of the per‑trade breakdown on request and manually signed the amendment on 10/06/2025. The disclosure clarifies beneficial ownership and trading price ranges but does not include derivative activity or other material changes to holdings beyond the corrected sale amount.
Positive
- Amendment corrects prior reporting error, improving disclosure accuracy
- Weighted average price disclosed ($16.18) and full trade price range provided
- Reporting person retains a substantial holding of 2,857,033 shares after the sale
Negative
- Insider sold 33,800 shares, creating modest insider liquidity which may attract investor attention
- Original Form 4 contained an incorrect share amount, indicating a prior reporting inaccuracy
Insights
TL;DR: Amendment corrects reported sale size; shows modest insider liquidity at market prices.
The amendment clarifies that 33,800 common shares were sold on 09/30/2025 at a weighted average of $16.18, with executed prices between $15.86 and $16.75. The reporter continues to hold 2,857,033 shares directly after the sale, indicating this was a relatively small monetization versus total holdings.
This is a corrective filing rather than a new trading plan; the main risk is investor confusion from the earlier misstatement. Expect no near‑term change in ownership control from this sale; if more sales are reported, watch aggregate dispositions over the next 30-90 days for potential signaling.
TL;DR: Filing demonstrates procedural compliance and readiness to provide per‑trade detail.
The amendment addresses an internal reporting error by restating the sale quantity and disclosing the weighted average price and price range. The attestation and manual signature show adherence to Section 16 reporting formalities and corrective disclosure norms.
Governance implications are limited: the corrected disclosure improves transparency. Monitor whether additional amendments or Form 5s follow if further reporting inconsistencies appear within the next 60 days.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 33,800 | $16.18 | $547K |
Footnotes (1)
- On October 2, 2025, the Reporting Person filed a Form 4 (the "Original Report") which incorrectly stated the total shares sold in the reported transaction in Table I - Column 4 of the Original Report.. The Reporting Person is filing this Form 4/A to amend and correct the discrepancy. The price reported in Column 4 represents a weighted average sales price of $16.18. These shares were sold in multiple transactions at prices ranging from $15.86 to $16.75, inclusive.
